We develop innovative hi-tech therapeutic applications for interventional medicine. Our main product is EchoLaser: the first and unique integrated Laser-Ultrasound system that allows diagnosis and micro-invasive treatment of benign and malignant lesions. EchoLaser uses the laser light transmitted by independent sources (up to 4) through extremely thin optical fibres (0,3 mm) inserted percutaneously under a proprietary ultrasound guiding system (which includes a planning and simulation software). EchoLaser Therapy can induce a cytoreduction process on benign lesions (eg: BPH, thyroid nodules, etc.) or destroy cancerous tissue of malignant lesions (eg: metastatic lymph nodes, liver cancer, etc.). Generally no general anesthesia is required. Procedures can be performed in outpatient regimen with consequent faster recovery after treatment.
We want to play an important role in the new frontier of Precision Medicine, which is more than genomics and bespoke pharmacological treatment, but includes more accurate imaging and non surgical treatments (eg ablation).
Core EchoLaser Therapy treatments are:
ModìLite – lesions of the neck, such as benign thyroid nodules and metastatic lymph nodes.
SoracteLite – urinary system disorders like Benign Prostatic Hyperplasia (BPH), producing a progressive reduction in the volume of the prostatic lobes and subsequent disappearance of the symptoms. SoracteLite is the first and only laser treatment for BPH performed through trans-perineal approach (reducing complications of traditional trans-urethral approach)
PBLite – primary and secondary malignant liver cancers by percutaneous insertion of optical fibres
Elesta is developing other EchoLaser Therapy applications on soft tissues lesions such as breast, pancreas and lung, with the same aim that has driven the company since its foundation: protect the health of patients by offering innovative therapeutic solutions that are as equally efficient as and less invasive than other existing mini-invasive treatments and traditional surgical treatments.
Develop and market high-tech devices for the treatment of soft tissue lesions.
Our products aim to protect the health of patients by offering innovative therapeutic solutions that are as equally efficient as and less invasive than traditional surgical treatments.
One of the key features of our therapeutic approach is the rapid post-treatment recovery for patients, that also ensures enormous advantages in economic and socio-health terms.